Related Content

A Synergy of CAR-T Hematotoxicity Scoring Tools

Biosimilar Uptake Surges After Order Set Change at Academic Infusion Center

How Manufacturers Make Decisions About Patient Assistance Programs


Dr. Anthony Trovato provides an overview of the recent and ongoing updates to the 340B Drug Pricing Program, what to expect for the future of the program and shares insight on how to maintain compliance.